Principal Financial Analyst
MiniMed
Summary
A Principal Financial Analyst specializing in Contract Manufacturing (CM) and Volumes is a senior-level finance leader who serves as the financial authority on all matters related to third-party manufacturing economics and volume-driven financial performance. This role combines deep cost accounting expertise with strategic analytical leadership, ensuring that contract manufacturing decisions are financially optimized, volume assumptions are rigorously validated, and enterprise financial outcomes are achieved with precision and accountability.
Job description
About the Role
A Principal Financial Analyst specializing in Contract Manufacturing (CM) and Volumes is a senior-level finance leader who serves as the financial authority on all matters related to third-party manufacturing economics and volume-driven financial performance. This role combines deep cost accounting expertise with strategic analytical leadership, ensuring that contract manufacturing decisions are financially optimized, volume assumptions are rigorously validated, and enterprise financial outcomes are achieved with precision and accountability.
This role is onsite 3 days per week in Northridge, CA.
Related to Contract Manufacturing
- Serve as the enterprise financial authority for all contract manufacturing operations
- Own end-to-end financial accountability for CM costs across the global network: Finished goods contract production costs, Component and sub-assembly
- Develop and maintain sophisticated CM cost models
- Lead CM financial governance framework including: contract financial review, cost escalation clause management, benchmarking, Make vs. buy financial analysis
- Assess financial health and risk of contract manufacturing partners
- Ensure financial reconciliation between CM operational plans and financial forecasts
- Identify and resolve disconnects between volume signals and CM cost projections
- Develop integrated COGS impact models for CM volume decisions
- Lead annual budget and quarterly forecast cycles for all CM and volume financials
Related to Volume Overall
- Identify and quantify financial gaps and risks within the IBP process
- Drive financial scenario planning to support decision-making
- Ensure alignment between IBP outputs and demand planning in OneStream
- Perform comprehensive volume variance analysis: Volume mix, Actual vs budget disconnects, absorption variance due to volume changes, other
- Partner with Commercial Finance on demand-side volume assumptions
- Partner with Operations on supply-side volume capabilities and constraints
This role operates at the highest individual contributor level, sitting at the nexus of Finance, Supply Chain, Commercial, and Operations — driving enterprise-wide financial planning integration through the IBP process while owning the financial dimensions of volume and inventory management.
Requirements
- Bachelor's degree in Finance, Accounting, Economics, or Supply Chain and 7+ years in FP&A, Supply Chain Finance, or Manufacturing Finance
- Or, advanced degree and 5+ years of experience
- Advanced Excel
- SAP/Oracle
- GAAP/IFRS knowledge
- MBA or Master's in Finance / Supply Chain preferred
- Standard costing, inventory valuation, absorption
- Medical Device, Pharma, or Manufacturing strongly preferred
Benefits
- Health, Dental & Vision Insurance
- Health Savings Account
- Healthcare Flexible Spending Account
- Life Insurance
- Long-Term Disability Leave
- Dependent Daycare Spending Account
- Incentive Plans
- 401(k) Matching
- Short-Term Disability Coverage
- Paid Time Off & Holidays
- Employee Stock Purchase Plan
- Employee Assistance Program
- Non-Qualified Retirement Plan Supplement
- Capital Accumulation Plan
- Short Term Incentive (STI)
Company overview
MiniMed is a leading medical device company specializing in diabetes management technologies, with a rich history dating back to its founding in 1983 by visionary entrepreneur Alfred E. Mann. Originally acquired by Medtronic in 2001, MiniMed recently became an independent publicly-traded company in 2026, trading on Nasdaq under the ticker "MMED" with a market capitalization of approximately $5.29 billion. The company is headquartered in Northridge, California, and employs nearly 8,000 dedicated professionals focused on advancing diabetes care. MiniMed is unique as the only diabetes technology company that manufactures both insulin pumps and continuous glucose monitors (CGMs), offering integrated systems like the MiniMed 780G system with SmartGuard technology. Their flagship products include automated insulin delivery systems, continuous glucose monitoring sensors, and smart insulin pens designed to simplify diabetes management and improve patient outcomes. With a mission to make diabetes more predictable and manageable, MiniMed has established itself as a pioneer in diabetes technology, providing innovative solutions that help patients achieve better glucose control and enhance their quality of life.